Kozaar

Roman name

Phentermine

The composition and the form of

1 tablet contains potassium lozartana 12.5, or 50 mg; in a contour acheikova packing 21 or 14 pc. , in box 2 and 1 package respectively.

Pharmacokinetics

Well drawn. Distributed relatively evenly. Metabolised education active derivative.

Farmakodinamika

Gipotenzivny maximum effect was achieved through the 3-6 weeks of treatment.

Indications

Arterial hypertension, heart failure (including the treatment cotton mills is no longer suitable for the patient.

Pregnancy and lactation

When a pregnancy reception immediately cease (can cause developmental disorders or death fruit, especially in the II quarter). Nursing mothers should stop breast-feeding.

Contraindications

Hypersensitivity, the children's age.

Side-Effects

Vertigo, gipotenzia (dozozawisimaya) giperkaliemia (1.5% of patients).

Patient interaction

Compatible with other antigipertenzivei means. While dioretikov (high doses) increases the risk of excessive hypotension in patients with dehydration.

Overdosing

The most apparent manifestation of-gipotenzia and tachycardia (wagusnaya possible aetiology). Treatment of symptomatic either Kozaar nor its active metabolite not showing haemodialysis.

Precautions

Patients with liver disease in history to appoint smaller doses (concentration in the plasma significantly increased on violations of their responsibilities, particularly with cirrhosis).

Dosing and Administration

Inside, regardless of meals, once. Usually -- 50 mg / sut. In some cases, in order to achieve greater economies of dose increase to 100 mg. In patients with dehydration initial dose may be 25 mg / sut. For patients with heart failure initial dose could reach 12.5 mg once a day.

Storage conditions

List B. The temperature 15-30 ° C

Shelf life

3 years

The registration

013242/01-2001

Directory → Organotropona funds → Cardiovascular funds → Receptor antagonists angiotenzina II (At_1-podtip) → Kozaar